Latest Breaking News On - Mohit bansal - Page 1 : comparemela.com

Viking, CRISPR, Cytokinetics are M&A targets: Wells Fargo

Viking, CRISPR, Cytokinetics are M&A targets: Wells Fargo
seekingalpha.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from seekingalpha.com Daily Mail and Mail on Sunday newspapers.

Moonlake immunotherapeuticsArcutis biotherapeuticsZealand pharmaVerona pharmaBridgebio pharmaMohit bansalNeurocrine biosciencesIovance biotherapeuticsWells fargoAlnylam pharmaceuticalsRhythm pharmaceuticalsApellis pharmaceuticalsArrowhead pharmaceuticalsAmicus therapeuticsXenon pharmaceuticalsMadrigal pharmaceuticals

Ironwood Pharmaceuticals, Inc (NASDAQ:IRWD) Q1 2024 Earnings Call Transcript

Ironwood Pharmaceuticals, Inc (NASDAQ:IRWD) Q1 2024 Earnings Call Transcript
insidermonkey.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from insidermonkey.com Daily Mail and Mail on Sunday newspapers.

United statesJason butlerAmy liDavid amsellemSravan emanyMatt roacheMike shetzlinePiper sandlerTom mccourtMohit bansalIronwood pharmaceuticals first quarterWells fargoIronwood pharmaceuticals incIronwood pharmaceuticalsCall transcript mayPrivate securities litigation reform act

Pfizer (PFE) Q1 2024 Earnings Call Transcript

PFE earnings call for the period ending March 31, 2024.

United statesSaudi arabiaKingdom of saudi arabiaCarter gouldCarter gould barclaysMohit bansalLouise chen cantor fitzgeraldDave risingerRajesh kumarTerence flynn morgan stanleyMikael dolstenRd doug lanklerGeoff meachamAamir malikTrung huynhFrancesca demartino

Pfizer (PFE) Q1 2024 Earnings Call Transcript

PFE earnings call for the period ending March 31, 2024.

Saudi arabiaUnited statesKingdom of saudi arabiaDave risingerMikael dolstenChris shibutani goldman sachsRajesh kumarCarter gould barclaysCarter gouldChris schottFrancesca demartinoChris shibutaniTerence flynn morgan stanleyLouise chen cantor fitzgeraldChrist schott jpmorganAkash tewari jefferies

Gilead Sciences, Inc (NASDAQ:GILD) Q1 2024 Earnings Call Transcript

Gilead Sciences, Inc. beats earnings expectations. Reported EPS is $-1.32, expectations were $-1.49. Gilead Sciences, Inc.

United statesJacquie rossSalveen richterDaina grayboschChris schottMerdad parseyJohanna mercierTyler van burenAndrew dickinsonGeoff meachamGoldman sachsCindy perettieJames shinMohit bansalCindy porettiMichael yee